Navigation Links
Ziosoft Receives FDA Clearance for CT Brain Perfusion Application
Date:1/8/2009

Brain perfusion application is accessible to clinicians throughout the enterprise using the Ziostation® thin-client system.

Redwood City, Calif (PRWEB) January 8, 2009 -- Ziosoft®, Inc., a leader in advanced visualization and analysis software for medical imaging, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its CT brain perfusion application.


The brain perfusion application is a powerful analysis tool used with the Ziostation thin-client system. The software is unique in its ability to provide brain perfusion functionality to clinicians as a thin-client application using standard commercial hardware. This software option aids radiologists in stroke assessment by providing a color map of cerebral blood flow and other perfusion-related parameters from CT images of the brain. The brain perfusion application includes image manipulation tools as well as measurement tools such as cerebral blood volume, blood flow and mean transit time. Ziosoft's brain perfusion application provides radiologists with decision support tools to accurately assess the type and extent of cerebral perfusion disturbance whether viewed in a hospital or at a remote location offering physicians flexibility and efficiency in viewing solutions.


"Because time to reach diagnosis and begin treatment for stroke victims is critical, we are pleased to provide this new brain perfusion application which can be accessed enterprise-wide," said Mark Koeniguer, Ziosoft's chief operating officer. "Results can also be accessed via a standard web-browser through Ziostation Web, demonstrating our commitment
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Medicsight Announces New Global Marketing Partnership with Ziosoft Unveiled at RSNA 2008
2. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
3. DaVita Receives Civil Complaint
4. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
5. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
6. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
7. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
8. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
9. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
10. Prime Therapeutics Receives TIPPS Certification
11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ziosoft Receives FDA Clearance for CT Brain Perfusion Application
Ziosoft Receives FDA Clearance for CT Brain Perfusion Application
(Date:12/4/2009)..., Dec. 4 The following ...hysicians and Surgeons (AAPS): , ,DATE: ...,PLACE: Grand Hyatt Hotel Washington ... Renwick Room (lower level 2),EVENT: ...e, opposition to U.S. Senate he...
(Date:12/4/2009)...N and HOUSTON, Dec. 4 AE...(Nasdaq: CYBX ) announced today that Vagus Nerve... implantable medical device for the treatment of r...ations at the American Epilepsy Society,s (AES) A...ynes Convention Center in Boston, Massachusetts. ...
(Date:12/4/2009)... North American Seminars Inc. is now accepting med...al education courses at their medical facility in ...ts operation and capabilities to the medical commu...ate their physical therapy and occupational therap...over 250 live training events. , ...
(Date:12/4/2009)... Best-Selling author and Personal & Organizati...al Transformation through Accountability! , ...er 4, 2009 -- IMPAQ Accountability Business Cons..., best-selling Author, renowned Speaker, and CEO &...ultants Inc., will present at the 14th Internation...
(Date:12/3/2009)..., Dec. 3 The American R...International Brotherhood of Teamsters, Local 929 ...leaving the facility, interfering with blood shipm....newscom.com/cgi-bin/prnh/20081216/DC52619LOGO ) ...nst the American Red Cross Blood Services Penn-Jer...
Breaking Medicine News(10 mins):Health News:State Legislators in D.C. To Blast Senate Healthcare Bill at News Conference; Say Tramples States' Rights, and Saddles with Massive Medicaid Bills; Push Bills to Block Federal Mandates 2Health News:NYU Langone Medical Center Study Shows VNS Therapy is a Safe and Effective Treatment for Refractory Epilepsy 2Health News:NYU Langone Medical Center Study Shows VNS Therapy is a Safe and Effective Treatment for Refractory Epilepsy 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 2Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 4Health News:Mark Samuel, CEO & Founder, IMPAQ Accountability Business Consultants Inc., to Present at 14th ICF Annual International Conference 2Health News:American Red Cross Wins Court Injunction Against Striking Teamsters 2
...an., June 5 Fort Dodge Animal Health, a,division ...oduction of,ProHeart(R) 6, a unique heartworm prev...uncement follows a review by the U.S. Food and Dru...on,to return this life-saving product to the marke...
...Spot for the World,s Longest Indoor Stair Climb Be...on, CHICAGO, June 5 Registration for Go Vertical...o the top of the Sears,Tower, opens at 9 a.m. CDT ... is limited to the first 2,250 registrants, and wi...
... it possible to restore function to a paralyzed li...s disease? These are two of the several topics th...erence, June 16-18, hosted by Case Western Reserve...lready provided substantive benefits to many indiv...
... Three-Year Plan -, SAN ANTONIO, June 5 American...American Heartworm Society president, Dr.,Sheldon ... conduct the most,comprehensive heartworm incidenc...e through corporate sponsorship, will be,distribut...
...ely to smoke, abuse drugs, alcohol, study finds , ...ns with bipolar disorder are at greater risk of s...eneral Hospital (MGH) study that supports previous...uvenile delinquency," study leader Dr. Timothy Wil...
...cs effects of caloric restriction to extend life s...ay News) -- Resveratrol, a compound found in grape... may protect the heart and slow the effects of agi... percent fewer calories than a typical diet that h...
Other Medicine News:Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 2Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 3Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 4Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 5Health News:Go Vertical Chicago 2008 Sears Tower Stair Climb Registration Opens June 10 2Health News:Go Vertical Chicago 2008 Sears Tower Stair Climb Registration Opens June 10 3Health News:Premier conference on neurotechnology and deep brain stimulation to be held in Cleveland June 16-18 2Health News:American Heartworm Society Announces Heartworm Incidence Survey 2Health News:Bipolar Teens at Greater Risk of Substance Abuse 2Health News:Red Wine Compound Helps Heart, May Slow Aging 2
(Date:12/3/2009)... WALTHAM, Mass., Dec. 3 Decision...d advisory firms focusing on pharmaceutical and he...s drug market in Brazil will grow from $417 millio...5 percent annual growth rate is attributed to a gr...ased use of new generation antidiabetics such as M...
(Date:12/3/2009)...S ANGELES, Dec. 3 Instac...ovider of life-saving prescription drugs, home tes...ulfillment provider of direct to patient diabetes ...hnology and revolutionary cell phone centric techn... file multiple updated and enhanced patent and tra...
(Date:12/3/2009)...IEGO, Dec. 3 Amira Pharmaceutica...m a Phase 1 clinical study of AM461, the Company,s... known as CRTH2) receptor. ,, The interim res...dynamic (PD) effect can be achieved with AM461. A...es a good safety profile. AM461 is a back-up to A...
Breaking Medicine Technology:Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 3Instacare Moves to Secure Patents for Its Newest Technologies, Announces Parallel Strategies for Its Revolutionary MD@Hand Cell-Centric Products 2Instacare Moves to Secure Patents for Its Newest Technologies, Announces Parallel Strategies for Its Revolutionary MD@Hand Cell-Centric Products 3Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amira's Lead DP2 Antagonist, AM211 2MedNet Solutions Named to the Inc 5000 List Three Years in a Row 54901 1MedNet Solutions Named to the Inc 5000 List Three Years in a Row 54901 2Nutrisystem Now Offers Double the Fresh Frozen Food for the Same Low Monthly Cost 54898 1Nutrisystem Now Offers Double the Fresh Frozen Food for the Same Low Monthly Cost 54898 2Nutrisystem Now Offers Double the Fresh Frozen Food for the Same Low Monthly Cost 54898 3Treatment May Limit Graft Versus Host Disease 54894 1Treatment May Limit Graft Versus Host Disease 54894 2
... in Stable Asthma and Exercise-Induced ...ING, Pa., March 18 Genaera,Corporation (Nasdaq: ...Immune, has initiated its fourth phase 2a clinical...dy (MAb) targeting interleukin-9 (IL-9), in,patien... assess the,potential of MEDI-528 in patients with...
...icromet, Inc.,(Nasdaq: MITI ), a biopharmaceutica... for the treatment of cancer, inflammation and aut... be presented on April 14, 2008,at the annual meet...ACR) to,be held at the San Diego Convention Center...gress on the company,s proprietary BiTE(R) antibod...
Other Medicine Technology:Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma 2Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma 3Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma 4Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 2Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 3Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 4Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 5
...ghly effective surgical alternative for the treatm...s positioned close to the high pressure zone of th...ree support of the urethra in the correct position...es, with minimal tissue dissection. Clinical studi...
...s, the PeaceKeeper 20 gauge multi-modality intraoc...Field comprehensive family of lightweight Eraser b... Combining highly effective bipolar hemostasis wit... in a single use, sterile instrument, the PeaceKee...
SUR-FIT® AutoLock® Urostomy Pouch with Accuseal® Tap
SUR-FIT Natura® Urostomy Pouch
Medicine Products: